MSB
MESOBLAST FPO [MSB]
Healthcare · ASX Small Cap
$2.0600 -8.0%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 4 consecutive scans→ Score +0First seen: 2026-02-25
Score Breakdown
Technical30
Catalyst51
Sentiment50
Fundamental77
Momentum67
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Price at lower Bollinger Band (oversold)
- Above-average volume (1.8x) on down day
- Sharp 5-day decline (-10.4%)
- Strong cash runway (9 quarters)
- Strong revenue growth (+1527%)
- EPS estimates revised upward (+10pts)
- Elevated short interest (7.2%)
- CANSLIM I: Institutional ownership (16%)
- Positive 12-1 momentum (+44%)
- Strong revenue momentum (+1527%)
- Days to cover very high (29.8)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2008-12-26)
Risk Signals
- MACD momentum weakening
- Price below MAs (downtrend)
- Breakdown below 20-day support
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-144%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Ryoncil Profits Underpinning Substantial Growth Pipeline
NONE Corporate Presentation and Half Year Financial Results
NONE Half Year Report and Accounts (including Appendix 4D)
Recent ASX Announcements
| 2026-02-26 | Ryoncil Profits Underpinning Substantial Growth Pipeline PRICE SENSITIVE |
| 2026-02-26 | Corporate Presentation and Half Year Financial Results PRICE SENSITIVE |
| 2026-02-26 | Half Year Report and Accounts (including Appendix 4D) PRICE SENSITIVE |
| 2026-02-20 | Mesoblast 2026 Half Year Financial Results Webcast |
| 2026-02-11 | High Survival Rates with Ryoncil in SR-aGvHD EIND Program |
Key Metrics
$2.9B
Market Cap
3.1M
Avg Volume
1.8x
Vol Ratio
$1.51 — $3.31
52-Week Range
7.2%
Short Interest
N/A
Cash Runway
-18.2%
ROE
-144.3%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 67% |
| L | Leader vs Laggard | laggard | RS: -4 |
| I | Institutional Sponsorship | pass | Inst: 16% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #53 of 119 · Sector avg: 51
View all Healthcare signals →